AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
The mission of Danone Research is to bring health through food to the greatest number of people.
With 150 manufacturing sites and over 75,000 employees, Danone is a health food leader. The waters division of the Danone Group encompasses several well known international brands including Evian, Volvic, Badoit and Bonafont, as well as leading national brands such as Aqua (Indonesia), Villavicencio, Villa del Sur (Argentina), Zywiec Zdroj (Poland), Hayat (Turkey), Fontvella, Lanjaron (Spain), Salus (Uruguay), Robust, Health (China) and Salvetat (France). Danone is committed to promoting healthy hydration. Our aim is to encourage scientific advances in hydration studies, and ensure the diffusion and application of this information through our the Hydration for Health Initiative.
Vifor Fresenius Medical Care Renal Pharma
The partner of choice for renal pharmaceuticals and innovative, patient-focused solutions
Vifor Fresenius Medical Care Renal Pharma is a strategic partnership between Vifor Pharma and Fresenius Medical Care, and a rapidly-growing international company that focuses on nephrology.
The company develops and commercialises high quality, innovative products that help patients with chronic kidney disease (CKD) to manage their condition and to live better, healthier and more fulfilling lives. We work in partnership with specialist clinics, healthcare professionals, payors and patients to offer them the most comprehensive portfolio of nephrology products. These cover five essential therapeutic areas: anaemia management; mineral & bone disorders management; cardio-renal management; CKD progression and kidney transplantation.
Vifor Fresenius Medical Care Renal Pharma is the partner of choice for innovative nephrology products. By combining pharmaceutical expertise and day-to-day understanding of the patient experience, Vifor Fresenius Medical Care Renal Pharma is continually seeking new ways to improve treatment options for clinicians and to drive better patient care, working to complement our unrivalled portfolio of nephrology medicines with new technologies and treatment modalities to provide truly integrated solutions.
Amgen discovers, develops, manufactures and delivers innovative human therapeutics.
A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.
Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor biology.
Akebia’s lead product candidate, vadadustat, is an oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients.
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
As a global, diversified healthcare company, Baxter International Inc. applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Fresenius Medical Care is the world’s largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.3 million individuals worldwide.
Through its network of 3,180 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to more than 261,600 patients around the globe. Fresenius Medical Care is also the world’s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.
Rik Bollaert, 世界肾脏日活动经费募集